Back to Market Maps

Neurotechnology

Technologies interfacing with the nervous system for medical and research applications

Market Size
$17.3B
Growth Rate
13% CAGR
Projected
$59.0B (2035)

Source: Precedence Research. Figures checked October 21, 2026.

Market Overview

Market Size

$17.3B (2025). Source: Precedence Research, Neurotechnology Market.

Projection

$59.0B (2035) (2026-2035).

Scope and other estimates

Covers neurostimulation, neurosensing, neuroprostheses and neurorehabilitation. Roots Analysis puts the 2024 market at $15.1B.

Description

Brain-computer interfaces, neural implants, neuroprosthetics

Key Technology Segments

Brain-Computer Interfaces

Direct communication between brain and external devices

TRL Range: TRL 5-7Market Size: $2.3B (2024) to $4.5B (2029) (BCC Research)
Key Players: Neuralink, Synchron, Blackrock Neurotech

Key Players and Research Institutions

Neuralink

startup

Implantable brain-computer interface in human clinical trials.

Private

Funding: About $1.3B raised (CB Insights)

Visit website →

Synchron

startup

Stentrode brain-computer interface implanted through blood vessels, in US and Australian clinical trials.

Private

Funding: About $336M raised (CB Insights)

Visit website →

Blackrock Neurotech

startup

Brain-computer interface hardware, majority-owned by Tether since a $200M investment in 2024. Unrelated to BlackRock Inc.

Private

Visit website →

Commercialization Pathways

Licensing

medium feasibility

Neurotech IP can be licensed to medical device companies.

Spinout

high feasibility

Strong investor interest in neurotechnology startups.

Partnership

high feasibility

Partnerships with medical device companies are common.

Regulatory Considerations

  • •FDA approval
  • •Medical device regulations
  • •Ethical considerations

Frequently Asked Questions

What is the market size for neurotechnology?

Precedence Research estimates market size at $17.3B (2025), reaching $59.0B (2035) (13% CAGR). Covers neurostimulation, neurosensing, neuroprostheses and neurorehabilitation. Roots Analysis puts the 2024 market at $15.1B.

What are the main commercialization pathways for neurotechnology?

The primary commercialization pathways include spinout, partnership. Spinouts are particularly viable given strong investor interest.

Which universities are leading in neurotechnology research?

Leading universities in neurotechnology include MIT, Stanford, UC Berkeley, and others. These institutions have strong research programs and commercialization track records in this area.

What are the key technology segments in neurotechnology?

Key technology segments include Brain-Computer Interfaces. These segments represent different areas of innovation and market opportunity within the broader neurotechnology category.